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Possible sulfadoxine-pyrimethamine resistance in 
Plasmodium falciparum malaria from Kenya 
Resistance of Plasmodium falciparum to treatment 
with a combination of sulfadoxine and pyrimethamine 
(‘Fansidar’) has been reported from South-East Asia 
and Brazil; as shown by the CENTER FOR DISEASE 
CONTROL (1980). FERNEX 11981). HOEFLER (1980). 
HOLZER ei al. ?1980), H&WIT: et al. (1981) and 
RUMANS et al. (1979). We have recently seen a patient 
returning from Kenya who failed to respond to this 
drug combination. 
A nreviouslv healthv 35year-old white man, who 
had never been to the-tropics before, spent a holiday 
in Kenva from Mav 1st to Mav 16th. From the 
beginning, and continuing after his return to Switzer- 
land, he regularly took ‘Fansidar’ for malaria prophy- 
laxis, one tablet weekly. At the end of May, still under 
‘Fansidar’ prophylaxis, he developed fever and his 
physician, a specialist m tropical medicine, diagnosed 
falciparum malaria. The patient was treated with 3 
tablets of ‘Fansidar’ (sulfadoxine 1.5 g/pyrimeth- 
amine 75 mg). For a concomittant urinary tract 
infection cotrimoxazole was prescribed. All symptoms 
subsided and the patient continued to take one tablet 
of ‘Fansidar’ weekly. 
On July 2nd, the patient again experienced an 
attack of ever and headache and subsequently every 
evening for seven days. He did not consult a physician 
again until July lOth, when he developed severe 
confusion and had to be admitted to the hospital. 
On admission, he was prostrated and severely 
disorientated. The temnerature was 39~6°C BP 120/ 
70, pulse rate 88/min. dtherwise the clinical-examina- 
tion revealed no particular findings. The thick and 
thin blood films showed tronhozoites of Plasmodium 
falciparum (parasite density less than 1%). Haemoglo- 
bin was 12.4 g/d& erythrocytes 3.92 x lO’*/l, WBC 
2.3 x 109/1, platelets 101 x 109/1. Creatinine and 
GOT were normal. 
Treatment was started with quinine, by intra- 
venous drip for the first 24 hours and then continued 
orally for 10 days at a dose of approximately 
22 mg/kgday. Definite fever and parasite clearance 
occurred after 48 hours, and the patient has remained 
well up to date. 
We had no possibility of more specific laboratory 
investigations. The question, therefore, remains 
open, if we were in fact dealing with a true ‘Fansidar’ 
resistance of P. falciparum, or if the obvious treatment 
failure was the consequence of poor bioavailability or 
abnormally rapid metabolism of the sulfonamide. The 
possible relevance of such factors has been shown by 
TRENHOLME et al. (1975) and WILLIAMS et al. (1978). 
The fact that the patient was not cured by a rather 
high dose of ‘Fansidar’ (prophylactic plus curative 
dose) and coincidentally received another antifol 
combination (cotrimoxazole) makes the former more 
probable. 
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The beliaviour of Glossina morsitans morsitans near 
roads 
During wet and dry seasons of 1976 and 1977 the 
behaviour of Glossina morsitans morsitans was studied 
along a 1Okm stretch of dirt road passing through 
Copaifera mopane woodland near Kakumbi, Eastern 
Zambia, just outside the Luangwa Valley National 
Park. Many species of tsetse-hosts abound there 
including elephant, hippopotamus, buffalo and 
